Fluidigm Corporation (NASDAQ:FLDM) insider Levin Capital Strategies, L.P. bought 60,000 shares of Fluidigm Corporation stock in a transaction that occurred on Thursday, October 19th. The shares were acquired at an average price of $4.55 per share, with a total value of $273,000.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Levin Capital Strategies, L.P. also recently made the following trade(s):

  • On Tuesday, October 17th, Levin Capital Strategies, L.P. purchased 144,200 shares of Fluidigm Corporation stock. The stock was purchased at an average price of $4.59 per share, with a total value of $661,878.00.
  • On Monday, October 9th, Levin Capital Strategies, L.P. purchased 50,000 shares of Fluidigm Corporation stock. The stock was purchased at an average price of $4.59 per share, with a total value of $229,500.00.
  • On Tuesday, October 10th, Levin Capital Strategies, L.P. purchased 95,843 shares of Fluidigm Corporation stock. The stock was purchased at an average price of $4.57 per share, with a total value of $438,002.51.
  • On Tuesday, September 12th, Levin Capital Strategies, L.P. purchased 60,000 shares of Fluidigm Corporation stock. The stock was purchased at an average price of $5.25 per share, with a total value of $315,000.00.
  • On Thursday, August 17th, Levin Capital Strategies, L.P. purchased 465 shares of Fluidigm Corporation stock. The stock was purchased at an average price of $3.66 per share, with a total value of $1,701.90.
  • On Thursday, August 10th, Levin Capital Strategies, L.P. purchased 4,003,129 shares of Fluidigm Corporation stock. The stock was purchased at an average price of $3.30 per share, with a total value of $13,210,325.70.
  • On Wednesday, August 9th, Levin Capital Strategies, L.P. purchased 1,549 shares of Fluidigm Corporation stock. The stock was purchased at an average price of $3.18 per share, with a total value of $4,925.82.

Shares of Fluidigm Corporation (NASDAQ FLDM) traded up 8.75% during midday trading on Monday, hitting $5.47. 583,533 shares of the company traded hands. The stock’s 50-day moving average is $4.98 and its 200 day moving average is $4.50. The stock’s market capitalization is $160.89 million. Fluidigm Corporation has a 12-month low of $2.52 and a 12-month high of $8.69.

Fluidigm Corporation (NASDAQ:FLDM) last issued its quarterly earnings data on Thursday, August 3rd. The medical research company reported ($0.58) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.60) by $0.02. The firm had revenue of $23.90 million during the quarter, compared to analysts’ expectations of $23.50 million. Fluidigm Corporation had a negative net margin of 74.05% and a negative return on equity of 121.04%. The business’s revenue for the quarter was down 15.2% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.63) earnings per share. On average, analysts expect that Fluidigm Corporation will post ($1.95) earnings per share for the current year.

WARNING: “Insider Buying: Fluidigm Corporation (FLDM) Insider Acquires 60,000 Shares of Stock” was originally published by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The original version of this article can be read at https://www.americanbankingnews.com/2017/10/23/insider-buying-fluidigm-corporation-fldm-insider-acquires-60000-shares-of-stock.html.

Several institutional investors have recently added to or reduced their stakes in the company. State Street Corp boosted its holdings in shares of Fluidigm Corporation by 6.2% in the second quarter. State Street Corp now owns 499,524 shares of the medical research company’s stock valued at $2,017,000 after buying an additional 29,110 shares during the period. PDT Partners LLC boosted its holdings in shares of Fluidigm Corporation by 56.0% in the second quarter. PDT Partners LLC now owns 27,300 shares of the medical research company’s stock valued at $110,000 after buying an additional 9,800 shares during the period. Dimensional Fund Advisors LP boosted its holdings in shares of Fluidigm Corporation by 9.3% in the second quarter. Dimensional Fund Advisors LP now owns 136,003 shares of the medical research company’s stock valued at $549,000 after buying an additional 11,557 shares during the period. Virtu KCG Holdings LLC acquired a new position in shares of Fluidigm Corporation in the second quarter valued at approximately $105,000. Finally, Northern Trust Corp boosted its holdings in shares of Fluidigm Corporation by 7.2% in the second quarter. Northern Trust Corp now owns 406,560 shares of the medical research company’s stock valued at $1,642,000 after buying an additional 27,400 shares during the period. Institutional investors own 88.85% of the company’s stock.

About Fluidigm Corporation

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.

Insider Buying and Selling by Quarter for Fluidigm Corporation (NASDAQ:FLDM)

Receive News & Ratings for Fluidigm Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm Corporation and related companies with MarketBeat.com's FREE daily email newsletter.